Pharmaceutical giant GSK has presented promising Phase I clinical trial results for its targeted ADC therapy (mocertatug rezetecan). The novel drug, aimed at the B7-H4 antigen, demonstrates exceptionally high efficacy against treatment-resistant ovarian cancer and advanced endometrial cancer, paving the way for large-scale Phase III trials later this year.

Read More

The government in Athens has announced plans to block access to platforms like TikTok and Instagram for anyone under 15. The Greek prime minister attributes the decision to rising sleep disorders and anxiety among teenagers. Similar steps have long been underway across various US states, where rolling out restrictions continues to face fierce legal pushback rooted in the Constitution.

Read More